Emerald Clinical is a global CRO dedicated to accelerating the development of innovative therapeutics by delivering comprehensive, high-quality clinical research solutions across international borders. With deep expertise spanning Phase I through Phase IV clinical trials, providing full CRO services, Emerald Clinical serves as a trusted strategic partner for biopharmaceutical innovators, academic medical centers, and healthcare institutions worldwide.

Cross-Border Strategic Expertise: Serves as a vital operational bridge between Eastern and Western markets?particularly within South Korea's advanced life sciences ecosystem?facilitating seamless multi-regional clinical trials (MRCTs) and regulatory harmonization.

Specialized Therapeutic Focus: Integrates cutting-edge decentralized trial technologies with deep expertise across Renal, Oncology, Immunology, and advanced therapies to accelerate life-changing treatments to patients.

Emerald Clinical is a leading global contract research organization (CRO) with over 25 years of experience, specializing in end-to-end clinical trial services across all therapeutic areas. Recognized for its strong early-phase capabilities and extensive site networks spanning the Asia-Pacific region and international markets, the company delivers comprehensive solutions including clinical operations, data management, biostatistics, and regulatory strategy. Backed by deep scientific expertise?particularly in complex fields such as oncology?Emerald Clinical provides tailored, high-quality trial execution designed to accelerate innovative therapeutics from development to patients worldwide.